Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
35
SGMT Quote, Financials, Valuation and Earnings
Last price:
$6.36
Seasonality move
:
16.6%
Day range:
$6.10 - $6.53
52-week range:
$1.73 - $11.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.73x
Volume:
633.3K
Avg. volume:
589K
1-year change:
37.12%
Market cap:
$205.7M
Revenue:
--
EPS (TTM):
-$1.79
Earnings Data
Next earnings date for SGMT
Mar 11
2026
Most recent earnings per share
-$0.40
Beat by $0.02
(Nov 13/2025)
Consensus Estimate
-$0.42
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SGMT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/11/2026 | Q4 | -- | -- | -- | -$0.42 | -- |
| 11/13/2025 | Q3 | -- | -- | -$0.40 | -$0.42 | $0.02 |
| 08/13/2025 | Q2 | -- | -- | -$0.32 | -$0.50 | $0.17 |
| 05/15/2025 | Q1 | -- | -- | -$0.56 | -$0.69 | $0.12 |
| 03/12/2025 | Q4 | -- | -- | -$0.50 | -$0.59 | $0.08 |
| 11/14/2024 | Q3 | -- | -- | -$0.45 | -$0.40 | -$0.05 |
| 08/14/2024 | Q2 | -- | -- | -$0.25 | -$0.35 | $0.10 |
| 05/15/2024 | Q1 | -- | -- | -$0.23 | -$0.38 | $0.15 |
| 03/25/2024 | Q4 | -- | -- | -$0.36 | -$0.56 | $0.21 |
| 11/13/2023 | Q3 | -- | $2M | -$0.30 | -$0.80 | $0.50 |
| 06/30/2023 | Q2 | -- | -- | -$0.32 | -$0.52 | $0.20 |
| 03/31/2023 | Q1 | -- | -- | -$0.31 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.34 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.32 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.41 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.26 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.19 | -- | -- |
Sagimet Biosciences, Inc. Earnings Questions
-
How Much did Sagimet Biosciences, Inc. Generate in Revenue Last Quarter?
Sagimet Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Sagimet Biosciences, Inc. Beat Earnings Last Quarter?
Sagimet Biosciences, Inc. announced earnings per share of -$0.40 which represents a beat of analyst forecast a -$0.42 per share.
-
Is Sagimet Biosciences, Inc. Profitable?
Sagimet Biosciences, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sagimet Biosciences, Inc. EPS Next Year?
Sagimet Biosciences, Inc.'s earnings are forecast to decrease from -$1.45 per share to -$1.51 per share next year representing a decrease of -16.27%.
-
When is Sagimet Biosciences, Inc.'s Earnings Date?
Sagimet Biosciences, Inc.'s next earnings date is March 11, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 28.81% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 43.66% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.97% over the past day.
